Advocate Spotlight: Kristin Keesen

We’ve said it before and we’ll say it again: advocacy isn’t for the faint of heart! Persistence is a key theme for many of our advocates. Kristin Keesen, stage III survivor and Grassroots Action Committee (GAC) member’s efforts recently paid…  Read More

Meet the One Million Strong: Jo-Ann C. from Ontario,Canada

Be a part of One Million Strong and tell us how colorectal cancer has impacted your life! Share your story now!  MEET JO-ANN Jo-Ann Cluney, Survivor Pickering, Ontario, Canada JO-ANN’S STORY I was diagnosed with Stage IIIB Colorectal Cancer in November…  Read More

New Trial Looks to Reduce Recurrence and Neuropathy for Stage III Patients

If you are diagnosed with stage III colon cancer, you will probably receive about six months of treatment with FOLFOX after surgery. Research shows that this treatment regimen helps prevent recurrence for some – but not all – patients with…  Read More

Chemo Delay After Surgery Reduces Survival Rates

A paper presented at the recent 2011 Gastrointestinal Cancers Symposium conference reported important evidence that, for colorectal cancer patients getting chemotherapy after surgery, the sooner the better. For people diagnosed with stage III colon cancer, stage II rectal cancer, or stage…  Read More

Leading GI Cancer Researcher Updates Patients

Last night, Dr. Edith Mitchell of Thomas Jefferson University Kimmel Cancer Center in Philadelphia, PA, updated colorectal cancer patients on the latest research and treatment news in an online webinar. Dr. Mitchell highlighted the most important news for colon and…  Read More